NEW PRODUCT LAUNCH ANTIXAN® edaravone

28/07/2021

ANTIXAN® edaravone is approved by ANMAT for the following indications:

  • Inhibition in the progression of functional disorders in patients with Amyotrophic Lateral Seclerosis (ALS)
  • Improve neurological symptoms, disorders in daily activities.

PRESENTATION:

  • 30 mg x 10 injection


						

					

					

												 

						 	

							 	
							 

							 

							 	
XXVI Argentine and International Congress of Clinical Oncology organized by the AAOC

							 	

							 		
November 8-10, the XXVI Argentine and International Congress of Clinical Oncology 2023 was held at La Rural, in the City of Buenos Aires, and Bioprofarma Bago was there.

							 	

							 	

							 		Read note
							 	

							 

						 

												 

						 	

							 	
							 

							 

							 	
26th ARGENTINE CONGRESS OF HEMATOLOGY organized by the Argentine Society of Hematology

							 	

							 		
Bioprofarma Bagó participated in the 26th Argentine Congress of Hematology 2023, which was held from November 1st to the 4th at its two venues: the Sheraton Hotel and the Costa Galana Hotel, in the City of Mar del Plata.

							 	

							 	

							 		Read note
							 	

							 

						 

												 

						 	

							 	
							 

							 

							 	
New Product Launch VETRANO®palbociclib

							 	

							 		
We are thrilled to present to our community the launch of the product VETRANO® palbociclib, for our Oncology Line.

							 	

							 	

							 		Read note